Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Social Psychiatry and Psychiatric Epidemiology
Published in: Social Psychiatry and Psychiatric Epidemiology 12/2014

01-12-2014 | Original Paper

Insomnia symptoms and subsequent psychotropic medication: a register-linked study with 5-year follow-up

Authors: Peija Haaramo, Tea Lallukka, Eero Lahelma, Christer Hublin, Ossi Rahkonen

Published in: Social Psychiatry and Psychiatric Epidemiology | Issue 12/2014

Login to get access

Abstract

Purpose

This study examined the associations of insomnia symptoms with subsequent psychotropic medication, reflecting mental health.

Methods

Postal baseline surveys among 40- to 60-year-old employees of the city of Helsinki, Finland, were collected in 2000–2002 (N = 6,227, response rate 67 %, 78 % women) and longitudinally linked with national register data on prescribed reimbursed medication. Insomnia symptoms at baseline comprised difficulties in initiating and maintaining sleep, and non-restorative sleep. All purchased psychotropic medication 5–7 years prior to and 5 years after baseline was included. Outcomes were any psychotropic medication; antidepressants; and anxiolytics, hypnotics, and sedatives. Covariates included socio-demographic and work-related factors, health behaviors, lifetime mental disorders, and prior psychotropic medication. Logistic regression analysis was used to calculate odds ratios (OR) and their 95 % confidence intervals (CI).

Results

Insomnia symptoms were associated with higher frequency of subsequent psychotropic medication prescriptions. The associations were strongest for frequent insomnia symptoms (women OR 3.55, 95 % CI 2.64–4.77; men OR 4.64, 95 % CI 2.49–8.66, adjusted for age and prior medication), but also rare and occasional symptoms were associated with psychotropic medication. Further adjustments had negligible effects.

Conclusions

Insomnia symptoms were associated with prescribed psychotropic medication during follow-up in a dose–response manner. Attention should be given to the prevention of insomnia symptoms to curb subsequent mental problems.
Literature
1.
Partinen M, Hublin C (2011) Epidemiology of sleep disorders. In: Kryger MH, Roth T, Dement WC (eds) Principles and practice of sleep medicine, 5th edn. Saunders, Elsevier, St. Louis, pp 694–715CrossRef
2.
Finnish Medicines Agency Fimea and Social Insurance Institution (2011) Finnish statistics on medicines 2010. Finnish Medicines Agency Fimea and Social Insurance Institution, Helsinki
3.
Paulose-Ram R, Safran MA, Jonas BS, Gu Q, Orwig D (2007) Trends in psychotropic medication use among U.S. adults. Pharmacoepidemiol Drug Saf 16:560–570PubMedCrossRef
4.
Sivertsen B, Krokstad S, Øverland S, Mykletun A (2009) The epidemiology of insomnia: associations with physical and mental health. The HUNT-2 study. J Psychosom Res 67:109–116PubMedCrossRef
5.
Paunio T, Korhonen T, Hublin C, Partinen M, Kivimäki M, Koskenvuo M et al (2009) Longitudinal study on poor sleep and life dissatisfaction in a nationwide cohort of twins. Am J Epidemiol 169:206–213PubMedCrossRef
6.
Léger D, Guilleminault C, Bader G, Lévy E, Paillard M (2002) Medical and socio-professional impact of insomnia. Sleep 25:625–629PubMed
7.
Simon GE, VonKorff M (1997) Prevalence, burden, and treatment of insomnia in primary care. Am J Psychiatry 154:1417–1423PubMed
8.
Sivertsen B, Krokstad S, Mykletun A, Øverland S (2009) Insomnia symptoms and use of health care services and medications: the HUNT-2 study. Behav Sleep Med 7:210–222PubMedCrossRef
9.
Ohayon MM, Lader MH (2002) Use of psychotropic medication in the general population of France, Germany, Italy, and the United Kingdom. J Clin Psychiatry 63:817–825PubMedCrossRef
10.
Colman I, Croudace TJ, Wadsworth ME, Jones PB (2008) Factors associated with antidepressant, anxiolytic and hypnotic use over 17 years in a national cohort. J Affect Disord 110:234–240PubMedCentralPubMedCrossRef
11.
Salo P, Sivertsen B, Oksanen T, Sjösten N, Pentti J, Virtanen M et al (2012) Insomnia symptoms as a predictor of incident treatment for depression: prospective cohort study of 40,791 men and women. Sleep Med 13:278–284PubMedCrossRef
12.
Ohayon MM, Caulet M (1996) Psychotropic medication and insomnia complaints in two epidemiological studies. Can J Psychiatry 41:457–464PubMed
13.
Ohayon MM, Caulet M, Priest RG, Guilleminault C (1998) Psychotropic medication consumption patterns in the UK general population. J Clin Epidemiol 51:273–283PubMedCrossRef
14.
15.
Hayward RA, Jordan KP, Croft P (2012) The relationship of primary health care use with persistence of insomnia: a prospective cohort study. BMC Fam Pract 13:8PubMedCentralPubMedCrossRef
16.
Lahelma E, Aittomäki A, Laaksonen M, Lallukka T, Martikainen P, Piha K et al (2013) Cohort profile: the Helsinki Health Study. Int J Epidemiol 42:722–730PubMedCrossRef
17.
18.
Jenkins CD, Stanton BA, Niemcryk SJ, Rose RM (1988) A scale for the estimation of sleep problems in clinical research. J Clin Epidemiol 41:313–321PubMedCrossRef
19.
Guidelines for ATC classification and DDD assignment, 2012 (2011) WHO Collaborating Centre for Drug Statistics Methodology, Oslo
20.
Working group appointed by the Finnish Society of Addiction Medicine (2010) Treatment of alcohol abuse. Current Care Summary. The Finnish Medical Society Duodecim, Helsinki (In Finnish, abstract in English)
21.
Arber S, Bote M, Meadows R (2009) Gender and socio-economic patterning of self-reported sleep problems in Britain. Soc Sci Med 68:281–289PubMedCrossRef
22.
Lallukka T, Rahkonen O, Lahelma E, Arber S (2010) Sleep complaints in middle-aged women and men: the contribution of working conditions and work-family conflicts. J Sleep Res 19:466–477PubMedCrossRef
23.
Laaksonen M, Lallukka T, Lahelma E, Partonen T (2012) Working conditions and psychotropic medication: a prospective cohort study. Soc Psychiatry Psychiatr Epidemiol 47:663–670PubMedCrossRef
24.
Wallander MA, Johansson S, Ruigomez A, Garcia Rodriguez LA, Jones R (2007) Morbidity associated with sleep disorders in primary care: a longitudinal cohort study. J Clin Psychiatry 9:338–345
25.
LeBlanc M, Mérette C, Savard J, Ivers H, Baillargeon L, Morin CM (2009) Incidence and risk factors of insomnia in a population-based sample. Sleep 32:1027–1037PubMedCentralPubMed
26.
Ilomäki J, Bell JS, Kauhanen J, Enlund H (2011) Heavy drinking and use of sedative or anxiolytic drugs among aging men: an 11-year follow-up of the FinDrink study. Ann Pharmacother 45:1240–1247PubMedCrossRef
27.
Baglioni C, Battagliese G, Feige B, Spiegelhalder K, Nissen C, Voderholzer U et al (2011) Insomnia as a predictor of depression: a meta-analytic evaluation of longitudinal epidemiological studies. J Affect Disord 135:10–19PubMedCrossRef
28.
Ramsawh H, Stein MB, Mellman TA (2011) Anxiety disorders. In: Kryger MH, Roth T, Dement WC (eds) Principles and practice of sleep medicine, 5th edn. Saunders, Elsevier, St. Louis, pp 1473–1487CrossRef
29.
Gujar N, Yoo SS, Hu P, Walker MP (2011) Sleep deprivation amplifies reactivity of brain reward networks, biasing the appraisal of positive emotional experiences. The Journal of Neuroscience 31:4466–4474
30.
Hublin C, Partinen M, Koskenvuo M, Kaprio J (2007) Sleep and mortality: a population-based 22-year follow-up study. Sleep 30:1245–1253PubMedCentralPubMed
31.
Chen PL, Lee WJ, Sun WZ, Oyang YJ, Fuh JL (2012) Risk of dementia in patients with insomnia and long-term use of hypnotics: a population-based retrospective cohort study. PLoS ONE 7:e49113PubMedCentralPubMedCrossRef
32.
Roth T (2009) Comorbid insomnia: current directions and future challenges. Am J Manag Care 15(Suppl):S6–S13PubMed
33.
Baglioni C, Spiegelhalder K, Nissen C, Riemann D (2011) Clinical implications of the causal relationship between insomnia and depression: how individually tailored treatment of sleeping difficulties could prevent the onset of depression. EPMA J 2:287–293PubMedCentralPubMedCrossRef
34.
Roos E, Lahelma E, Saastamoinen P, Elstad JI (2005) The association of employment status and family status with health among women and men in four Nordic countries. Scand J Public Health 33:250–260PubMedCrossRef
35.
Laaksonen M, Aittomäki A, Lallukka T, Rahkonen O, Saastamoinen P, Silventoinen K et al (2008) Register-based study among employees showed small nonparticipation bias in health surveys and check-ups. J Clin Epidemiol 61:900–906PubMedCrossRef
36.
Vercambre M, Gilbert F (2012) Respondents in an epidemiologic survey had fewer psychotropic prescriptions than nonrespondents: an insight into health-related selection bias using routine health insurance data. J Clin Epi 65:1181–1189CrossRef
37.
Moul DE, Hall M, Pilkonis PA, Buysse DJ (2004) Self-report measures of insomnia in adults: rationales, choices, and needs. Sleep Med Rev 8:177–198PubMedCrossRef
38.
American Psychiatric Association (2000) Diagnostic and statistical manual of mental disorders, 4th edn, text revision. American Psychiatric Association, Washington, DC
39.
Julius RJ, Novitsky MA Jr, Dubin WR (2009) Medication adherence: a review of the literature and implications for clinical practice. J Psychiatr Pract 15:34–44PubMedCrossRef
40.
Hämäläinen J, Isometsä E, Laukkala T, Kaprio J, Poikolainen K, Heikkinen M et al (2004) Use of health services for major depressive episode in Finland. J Affect Disord 79:105–112PubMedCrossRef
41.
Morin CM, Bélanger L, LeBlanc M, Ivers H, Savard J, Espie CA et al (2009) The natural history of insomnia: a population-based 3-year longitudinal study. Arch Intern Med 169:447–453PubMedCrossRef
Metadata
Title
Insomnia symptoms and subsequent psychotropic medication: a register-linked study with 5-year follow-up
Authors
Peija Haaramo
Tea Lallukka
Eero Lahelma
Christer Hublin
Ossi Rahkonen
Publication date
01-12-2014
Publisher
Springer Berlin Heidelberg
Published in
Social Psychiatry and Psychiatric Epidemiology / Issue 12/2014
Print ISSN: 0933-7954
Electronic ISSN: 1433-9285
DOI
https://doi.org/10.1007/s00127-014-0862-8

Other articles of this Issue 12/2014

Social Psychiatry and Psychiatric Epidemiology 12/2014 Go to the issue

Original Paper

Patient, psychiatrist and family carer experiences of community treatment orders: qualitative study

Original Paper

Desire for information of people with severe mental illness

Original Paper

The influence of deprivation on suicide mortality in urban and rural Queensland: an ecological analysis

Original Paper

A supportive family environment in childhood enhances the level and heritability of sense of coherence in early adulthood

Invited Reviews

CTOs: what is the state of the evidence?

Original Paper

Physical diseases among persons with obsessive compulsive symptoms and disorder: a general population study